NCT07135531View on ClinicalTrials.gov

Continuous Glucose Monitoring (CGM) in an Underserved Population

NANot yet recruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

DiabetesDiabetes MellitusDiabetes Type 2

Interventions

DEVICE

Continuous Glucose Monitoring (CGM)

Continuous glucose monitors will be placed subcutaneously every 14 days.

Trial Locations (1)

70112

University Medical Center, New Orleans

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Tulane University

OTHER